Russell Frank Company’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Russell Frank Company’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$273K	Sell	13,352 -4,315	-24%	-$137K	﹤0.01%	2620
2015 Q4	$912K	Buy	17,667 +3,320	+23%	+$161K	﹤0.01%	2259
2015 Q3	$611K	Buy	+14,347	New	+$692K	﹤0.01%	2414
2013 Q4	–	Sell	-9,010	Closed	-$241K	–	3179
2013 Q3	$241K	Buy	9,010 +52	+0.6%	+$1.24K	﹤0.01%	2715
2013 Q2	$220K	Buy	+8,958	New	+$178K	﹤0.01%	2559

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Russell Frank Company's PTLA Position: Q1 2016 in Review

Russell Frank Company reduced its Portola Pharmaceuticals, Inc. (PTLA) stake by 24% in Q1 2016, selling an estimated $137K and leaving 13,352 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Russell Frank Company first reported a position in PTLA in Q2 2013 and has held it in 5 quarters since. The position peaked at $912K in Q4 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

Russell Frank Company held 13,352 shares of Portola Pharmaceuticals, Inc. worth $273K as of Q1 2016.
Russell Frank Company sold 4,315 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $137K.
Portola Pharmaceuticals, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2620 holding.
Russell Frank Company first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and has held it in 5 quarters since.
Russell Frank Company's Portola Pharmaceuticals, Inc. position peaked at $912K in Q4 2015.
167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.